Based on our observations, hyperactivation of AKT/mTOR signaling promotes the KRAS-G12D mutation-induced rewiring of amino acid metabolism, which compromises the growth of B-ALL cells; this conclusion is supported by our evidence showing that chemically inhibiting mTOR rescued the growth defects of RASmt cells in vivo. This evidence concerns the gene KRAS and acute lymphoblastic leukemia.